Virtus Lifesci Biotech Clinical Trials ETF (BBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBC | VHT | XBI | ||
| Company | Virtus Lifesci Biotech Clinical Trials ETF | Healthcare ETF Vanguard | S&P Biotech SPDR | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NYSE Arca | ||
| Open | 44.33 | 271.14 | 133.87 | ||
| High | 44.72 | 271.83 | 135.88 | ||
| Low | 44.31 | 268.39 | 133.27 | ||
| Latest | 44.61 | 268.98 | 134.71 | ||
| Change | +0.39 | -2.11 | +1.05 | ||
| % Change | +0.89% | -0.78% | +0.79% | ||
| Volume | 10,800 | 211,400 | 11,783,700 | ||
| 20-Day Average Volume | 26,755 | 193,185 | 8,190,215 | ||
| Previous Close | 44.22 | 271.09 | 133.66 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 45.44 | 272.72 | 134.29 | ||
| 20-Day Raw Stochastic | 36.08% | 25.67% | 60.80% | ||
| 20-Day Relative Strength | 52.35 | 42.97 | 55.10 | ||
| Weighted Alpha | +141.49 | +6.90 | +70.21 | ||
| Today's Opinion | 88% Buy | 72% Sell | 100% Buy | ||
| Previous Opinion | 88% Buy | 72% Sell | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 8% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.82% since 05/01/26 | -0.86% since 05/01/26 | +3.29% since 05/01/26 | ||
| Low | 43.57 on 05/04/26 | 268.39 on 05/08/26 | 129.80 on 05/04/26 | ||
| High | 46.04 on 05/07/26 | 274.08 on 05/06/26 | 137.95 on 05/06/26 | ||
| 1-Month | |||||
| %Chg | +2.72% since 04/08/26 | -3.31% since 04/08/26 | +3.11% since 04/08/26 | ||
| Low | 42.60 on 04/29/26 | 265.44 on 04/29/26 | 127.76 on 04/29/26 | ||
| High | 48.18 on 04/21/26 | 279.23 on 04/14/26 | 139.19 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +9.16% since 02/06/26 | -7.63% since 02/06/26 | +7.33% since 02/06/26 | ||
| Low | 38.63 on 03/30/26 | 264.97 on 03/27/26 | 118.19 on 03/24/26 | ||
| High | 48.18 on 04/21/26 | 295.64 on 02/27/26 | 139.19 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | +50.27% since 11/07/25 | -1.35% since 11/07/25 | +23.63% since 11/07/25 | ||
| Low | 30.47 on 11/11/25 | 264.97 on 03/27/26 | 109.28 on 11/10/25 | ||
| High | 48.18 on 04/21/26 | 298.61 on 01/07/26 | 139.19 on 04/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 37,921 | 15,998,931 | 8,594,498 | ||
| Shares Outstanding, K | 850 | 59,480 | 63,800 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 0.91 | 0.62 | 0.85 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.655 on 12/22/25 | 0.994 on 03/24/26 | 0.407 on 12/22/25 | ||
| Next Ex-Dividends Date | 12/22/25 | 03/24/26 | 12/22/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.90 | 18.68 | ||